Sanpower seals groundbreaking medical deal

Conglomerate boosts China's push to revolutionise its health sector by buying US biotech pioneer Dendreon. It complements Sanpower's previous investment in more prosaic health assets.

Sanpower seals groundbreaking medical deal

A vacuum in quality healthcare has emerged as a key challenge for the world's most populous nation, as policymakers wrestle with problems including a shortage of skilled professionals, slow drug clearance procedures and services that are unaffordable to most ordinary Chinese.

President Xi Jinping put the issue in perspective at August's National Healthcare Conference when he said it was at the heart of the country's policy-making machinery. State leaders later approved the “Healthy China...

FinanceAsia has updated its subscription model. Registered readers now have the opportunity to read five articles from our award-winning website for free. Please subscribe for unlimited access.

Print Edition

FinanceAsia Print Edition